finance · November 5, 2026
CVS Health plans $117 billion breakup into two public companies
What the sources reported
CVS Health sets 2028 separation for $117 billion group
CVS Health announced its intent to split into two independent, publicly traded companies. The company expects to complete the separation in the first half of 2028, ending a structure that brought retail pharmacies, health insurance and pharmacy benefits under one corporate roof.
The plan affects a business described in reports as worth $117 billion. It is a corporate reorganization rather than an announced change to pharmacy prices, insurance premiums or customer fees. For practitioners tracking healthcare finance, the immediate change is the separation of businesses that currently sit inside the same company and operate across the consumer healthcare chain.
The company’s announcement said the two companies would each focus on healthcare innovation. CVS Pharmacy would hold the retail pharmacy network, while Aetna, CVS Caremark and Oak Street Health would be kept together on the insurance and pharmacy-benefits side.
Roughly 9000 drugstores move into a standalone CVS Pharmacy
The retail business would move into a new company called CVS Pharmacy, encompassing roughly 9000 drugstores. CVS Health would return to being a standalone pharmacy chain after combining with Aetna in a transaction that also brought Caremark into the group.
The separation gives retail pharmacy operations a distinct corporate identity from health insurance and pharmacy-benefit management. It also changes the organizational boundaries across which some CVS services have historically been connected.
No new store openings, closures, prescription prices, copayments or service changes were announced in the available reporting. The disclosed timetable centers on completion of the separation in the first half of 2028 rather than an immediate change to pharmacy counters or insurance policies.
Aetna and Caremark stay within the insurance-focused company
Aetna and CVS Caremark will remain together after the breakup, with Oak Street Health also assigned to that side of the proposed structure. The insurer and pharmacy-benefits business will therefore be housed in a combined company rather than divided in the announced transaction.
That allocation brings together the parts of CVS Health associated with insurance margins and pharmacy-benefit services. The available evidence identifies the operating and strategic rationale behind the split but does not provide revised revenue, earnings, capital or debt figures for either prospective company.
For financial-analysis workflows, the announced change establishes a new reporting perimeter: a standalone CVS Pharmacy and a separate company combining Aetna, CVS Caremark and Oak Street Health. It does not yet specify the detailed financial allocations needed to model each business independently.
Public-company structure will change during 2028
Both resulting entities are intended to be publicly traded, according to CVS Health’s announcement. The separation is planned for the first half of 2028, making corporate structure and disclosure changes the clearest immediate consequence of the announcement.
The available reporting does not state when the operational separation will begin, when comparative financial statements will be presented or where the two companies will be listed. It also does not specify any changes to Aetna premiums, CVS Caremark contracts, CVS Pharmacy reimbursement arrangements or Oak Street Health services.
That leaves the transaction at the announced-plan stage. The disclosed milestone is the separation itself in the first half of 2028; follow-up disclosures are expected to clarify how the businesses, contracts and financial information will be organized on that basis.
Practical checks for healthcare finance and payment analysis
The first concrete checkpoint is CVS Health’s separation into two publicly traded companies in the first half of 2028. Before that deadline, the company’s follow-up disclosures are the relevant place to check for the operating perimeter of CVS Pharmacy, the treatment of Aetna and CVS Caremark, and the financial information presented for the two businesses.
The announcement also creates a potential need to track payments and pricing across formerly integrated operations. CVS Pharmacy will house roughly 9000 drugstores, while the other company will retain Aetna, CVS Caremark and Oak Street Health. Any comparison of prescription pricing, insurance economics or pharmacy-benefit economics will need to distinguish those entities once separate reporting becomes available.
The evidence does not identify a consumer fee change, premium adjustment or prescription-price change tied to the breakup. It identifies a corporate split, a named pharmacy company, a defined insurance grouping and a completion window.
What this means for tooling
- corporate separation tracker
- healthcare company comparison calculator
- pharmacy and insurance payment analyzer
- public-company filing monitor
Tools that already cover this
Decision room queued — the team review of this signal has not started yet.
AI analysis by Lizely. Grounded in linked public evidence. Participants are fictional editorial roles, not real people or human authors.